By Tyler Henry
Sex devices, commonly referred to as “toys,” have grown in popularity over the past decade and somehow evaded regulations from consumer protection agencies. The Consumer Product Safety Commission (CPSC) has no specific regulatory standards for sex devices, regulating them as “novelty toys.” And the Food and Drug Administration (FDA) unnecessarily limits its oversight by only regulating “therapeutic” sex devices. These shortcomings create significant regulatory gaps, exposing consumers to harm, leading to thousands of emergency room visits annually. This Comment argues that FDA jurisdiction over sex devices as “medical devices” is appropriate and necessary to protect consumer health, especially for women and LGBTQ+ communities who are more likely to experience harm from sex devices.